Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting

Citation
We. Trick et al., Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting, J THOR SURG, 119(1), 2000, pp. 108-114
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
ISSN journal
00225223 → ACNP
Volume
119
Issue
1
Year of publication
2000
Pages
108 - 114
Database
ISI
SICI code
0022-5223(200001)119:1<108:MRFAWD>2.0.ZU;2-A
Abstract
Objective: Our objective was to identify risk factors for deep sternal site infection after coronary artery bypass grafting at a community hospital. M ethods: We compared the prevalence of deep sternal site infection among pat ients having coronary artery bypass grafting during the study (January 1995 -March 1998) and pre-study (January 1992-December 1994) periods. We compare d any patient having a deep sternal site infection after coronary artery by pass graft surgery during the study period (case-patients) with randomly se lected patients who had coronary artery bypass graft surgery but no deep st ernal site infection during the same period (control-patients), Results: De ep sternal site infections were significantly more common during the study than during the pre-study period (30/1796 [1.7%] vs 9/1232 [0.7%]; P =.04). Among 30 case-patients, 29 (97%) returned to the operating room for sterna l debridement or rewiring, and 2 (7%) died. In multivariable analyses, cefu roxime receipt 2 hours or more before incision (odds ratio = 5.0), diabetes mellitus with a preoperative blood glucose level of 200 mg/dL or more (odd s ratio = 10.2), and staple use for skin closure (odds ratio = 4.0) were in dependent risk factors for deep sternal site infection. Staple use was a ri sk factor only for patients with a normal body mass index. Conclusions: App ropriate timing of antimicrobial prophylaxis, control of preoperative blood glucose levels, and avoidance of staple use in patients with a normal body mass index should prevent deep sternal site infection after coronary arter y bypass graft operations.